| 101 |
25894154 | Polymorphism of the CYP3A5 gene and its effect on tacrolimus blood level. | 2015 Apr |
2 |
| 102 |
25916520 | Relationship between mRNA expression levels of CYP3A4, CYP3A5 and SXR in peripheral mononuclear blood cells and aging in young kidney transplant recipients under tacrolimus treatment. | 2015 |
4 |
| 103 |
25968921 | Involvement of CYP 3A5 In the Interaction Between Tacrolimus and Nicardipine: A Case Report. | 2015 |
2 |
| 104 |
26039043 | Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis. | 2015 |
10 |
| 105 |
26067485 | Multigene predictors of tacrolimus exposure in kidney transplant recipients. | 2015 Jul |
1 |
| 106 |
26114223 | Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. | 2015 Sep |
3 |
| 107 |
26184414 | Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease. | 2015 Sep |
1 |
| 108 |
26227094 | The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. | 2015 Sep |
1 |
| 109 |
26228923 | Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients. | 2015 |
2 |
| 110 |
26271661 | Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients. | 2015 Dec |
2 |
| 111 |
26334901 | Donor PPARĪ± Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study. | 2015 Sep |
4 |
| 112 |
26615671 | Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase. | 2015 Dec |
2 |
| 113 |
26770526 | Relationships of related genetic polymorphisms and individualized medication of tacrolimus in patients with renal transplantation. | 2015 |
2 |
| 114 |
24033383 | Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short-term remission in patients with ulcerative colitis treated with tacrolimus. | 2014 Jan |
1 |
| 115 |
24061445 | Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients. | 2014 Feb |
1 |
| 116 |
24126681 | Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearance. | 2014 Apr |
2 |
| 117 |
24249597 | The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation. | 2014 Feb |
2 |
| 118 |
24369269 | Successful telaprevir treatment in combination of cyclosporine against recurrence of hepatitis C in the Japanese liver transplant patients. | 2014 |
1 |
| 119 |
24444408 | CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients. | 2014 Feb |
1 |
| 120 |
24462213 | Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. | 2014 Apr 15 |
4 |
| 121 |
24522145 | Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation. | 2014 Feb 12 |
1 |
| 122 |
24526611 | Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach. | 2014 May |
1 |
| 123 |
24656020 | Effects of elevated tacrolimus trough levels in association with infectious enteritis on graft function in renal transplant recipients. | 2014 |
1 |
| 124 |
24658827 | The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. | 2014 Jun |
1 |
| 125 |
24739669 | CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients. | 2014 Dec |
1 |
| 126 |
25125128 | Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus. | 2014 Oct |
1 |
| 127 |
25141896 | Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. | 2014 Jun |
1 |
| 128 |
25322286 | Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients. | 2014 Dec |
2 |
| 129 |
25561870 | Modulation of CYP2D6 and CYP3A4 metabolic activities by Ferula asafetida resin. | 2014 Dec |
1 |
| 130 |
28346678 | CORRIGENDUM: Identification and Characterization of a Defective CYP3A4 Genotype in a Kidney Transplant Patient With Severely Diminished Tacrolimus Clearance. | 2014 Nov |
1 |
| 131 |
23107770 | Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients. | 2013 Jan 10 |
4 |
| 132 |
23163400 | The CYP3A4*22 allele affects the predictive value of a pharmacogenetic algorithm predicting tacrolimus predose concentrations. | 2013 Jun |
1 |
| 133 |
23175667 | Increased hospital stay and allograft dysfunction in renal transplant recipients with Cyp2c19 AA variant in SNP rs4244285. | 2013 Feb |
2 |
| 134 |
23252948 | CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy. | 2013 Jan |
4 |
| 135 |
23278282 | Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. | 2013 Jul |
3 |
| 136 |
23364483 | CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). | 2013 Mar 27 |
1 |
| 137 |
23459029 | Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis. | 2013 May |
7 |
| 138 |
23481136 | Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients. | 2013 Mar-Apr |
2 |
| 139 |
23557867 | CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients. | 2013 Jun |
4 |
| 140 |
23574377 | Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms. | 2013 Aug |
1 |
| 141 |
23617933 | Biological interactions of CYP2C19 genotypes with CYP3A4*18, CYP3A5*3, and MDR1-3435 in living donor liver transplantation recipients. | 2013 Apr 23 |
1 |
| 142 |
23778326 | A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients. | 2013 Aug |
2 |
| 143 |
23837477 | CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients. | 2013 Jul |
8 |
| 144 |
23947183 | [Personalized medicine in transplantation therapy]. | 2013 May |
1 |
| 145 |
24024898 | Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism. | 2013 Sep |
1 |
| 146 |
24052064 | Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines. | 2013 Oct |
3 |
| 147 |
24189425 | Influence of cytochrome P450 (CYP) 3A4*1G polymorphism on the pharmacokinetics of tacrolimus, probability of acute cellular rejection, and mRNA expression level of CYP3A5 rather than CYP3A4 in living-donor liver transplant patients. | 2013 |
2 |
| 148 |
22108237 | The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients. | 2012 Jan |
1 |
| 149 |
22205779 | Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. | 2012 Apr |
1 |
| 150 |
22310591 | Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients. | 2012 Jan |
4 |